Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Raderer

Showing results (111-120 of 264) with videos related to

Pageof 27
Sort By:
Annals of Hematology|December 22, 2011
Plasmacytic differentiation in MALT lymphomas following treatment with rituximabMarlene Troch, Barbara Kiesewetter, Werner Dolak, et al.
Annals of Hematology|January 13, 2015
Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-upMarkus Raderer, Stefan Wöhrer, Barbara Kiesewetter, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 1, 2017
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at stagingChiara Giraudo, Georgios Karanikas, Michael Weber, et al.
Hematological Oncology|August 24, 2017
Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)Barbara Kiesewetter, Ingrid Simonitsch-Klupp, Christoph Kornauth, et al.
Oncology|January 7, 2004
Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphomaMarkus Raderer, Gerald Jäger, Stefan Brugger, et al.
Hematological Oncology|July 12, 2017
A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphomaBarbara Kiesewetter, Ortrun Neuper, Marius E Mayerhoefer, et al.
World Journal of Surgery|May 23, 2002
Treatment of small intestinal neuroendocrine tumors: is an extended multimodal approach justified?Martin Schindl, Klaus Kaczirek, Christian Passler, et al.
Haematologica|December 20, 2011
Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphomaConstanze Jonak, Marlene Troch, Barbara Kiesewetter, et al.
Oncology|August 14, 2017
Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center ExperienceDoris Posch, Werner Rabitsch, Philipp Wohlfarth, et al.
Blood Advances|March 3, 2026
Field-testing the MALT-IPI in a single center real-world cohort of patients with extranodal marginal zone lymphomaVincent Sunder-Plassmann, Barbara Kiesewetter, Ingrid Simonitsch-Klupp, et al.
Pageof 27

Showing results (111-120 of 264) with videos related to

Sort By:
Pageof 27
Annals of Hematology|December 22, 2011
Plasmacytic differentiation in MALT lymphomas following treatment with rituximabMarlene Troch, Barbara Kiesewetter, Werner Dolak, et al.
Annals of Hematology|January 13, 2015
Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-upMarkus Raderer, Stefan Wöhrer, Barbara Kiesewetter, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 1, 2017
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at stagingChiara Giraudo, Georgios Karanikas, Michael Weber, et al.
Hematological Oncology|August 24, 2017
Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma)Barbara Kiesewetter, Ingrid Simonitsch-Klupp, Christoph Kornauth, et al.
Oncology|January 7, 2004
Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphomaMarkus Raderer, Gerald Jäger, Stefan Brugger, et al.
Hematological Oncology|July 12, 2017
A pilot phase II study of ofatumumab monotherapy for extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphomaBarbara Kiesewetter, Ortrun Neuper, Marius E Mayerhoefer, et al.
World Journal of Surgery|May 23, 2002
Treatment of small intestinal neuroendocrine tumors: is an extended multimodal approach justified?Martin Schindl, Klaus Kaczirek, Christian Passler, et al.
Haematologica|December 20, 2011
Subcutaneous dissemination pattern in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue lymphomaConstanze Jonak, Marlene Troch, Barbara Kiesewetter, et al.
Oncology|August 14, 2017
Gender-Specific Aspects in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: A Single-Center ExperienceDoris Posch, Werner Rabitsch, Philipp Wohlfarth, et al.
Blood Advances|March 3, 2026
Field-testing the MALT-IPI in a single center real-world cohort of patients with extranodal marginal zone lymphomaVincent Sunder-Plassmann, Barbara Kiesewetter, Ingrid Simonitsch-Klupp, et al.
Pageof 27